Identification of Polo-like kinases as potential novel drug targets for influenza A virus
Abstract In recent years genome-wide RNAi screens have revealed hundreds of cellular factors required for influenza virus infections in human cells. The long-term goal is to establish some of them as drug targets for the development of the next generation of antivirals against influenza. We found th...
Guardado en:
Autores principales: | Marie O. Pohl, Jessica von Recum-Knepper, Ariel Rodriguez-Frandsen, Caroline Lanz, Emilio Yángüez, Stephen Soonthornvacharin, Thorsten Wolff, Sumit K. Chanda, Silke Stertz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e32cf9c0d02e4584918dacbc8b49c6cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cathepsin W Is Required for Escape of Influenza A Virus from Late Endosomes
por: Thomas O. Edinger, et al.
Publicado: (2015) -
Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target
por: Emilio Yángüez, et al.
Publicado: (2018) -
Phase separation of Polo-like kinase 4 by autoactivation and clustering drives centriole biogenesis
por: Jung-Eun Park, et al.
Publicado: (2019) -
Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
por: Ramesh L. Sawant, et al.
Publicado: (2021) -
Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers
por: Stratmann JA, et al.
Publicado: (2019)